Indications for Autotransfusion in Surgical Oncology

Blumberg N. Heal J.M. : Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med, 118: 371–379, 1994.

Tartter P.I. : The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg, 216: 633–638, 1992.

Friedmann B.A. Overmann H.A. Chadwich A.R. : The maximum blood order schedule and surgical blood use in the United States. Transfusion, 17: 163–168, 1986.

Mercuriali F. Inghilleri G. : Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin, 13: 465–478, 1996.

Gillon J. Thomas M.J.G. Desmond M.J. : Acute normovolemic hemodilution. Transfusion, 36: 640–643, 1996.

Brecher M.E. Rosenfeld M. : Mathematical and computer modeling of acute normovolemic hemodilution. Transfusion, 34: 176–179, 1994.

Desmond M.J. Thomas M.J.G. Gillon J. Fox M.A. : Perioperative red cell salvage. Transfusion, 36: 644–651, 1996.

Umlas J. Foster S.A. Dalal S.A. O'Leary S.M. Garcia L. Kruskall M.S. : Red cell loss following orthopedic surgery: the case against postoperative salvage. Transfusion, 34: 402–406, 1994.

Hansen E. Altmeppen J. Taeger K. : Autologous haemotherapy in malignant diseases. Ballière's Clin Anaesthesiol, 11: 335–49, 1997.

Hebert P.C. Hu L.Q. Biro G.P. : Review of physiologic mechanisms in response to anemia. Can Med Assoc J, 157(11 Sup-pi): S27–S40, 1997.

Mercuriali F. Biffi E. Inghilleri G. Vinci A. : Low hematocrit: limiting factor in autologous blood predonation program. In: Transfusion in Europe, Castelli D , Genetet B , Habibi B , Nyddeger Y (Eds), pp 291–298, Arnette SA Paris ISBT, Paris, 1989.

Miller C.B. Jones R.J. Piantadosi S. Abeloff M.D. Spivak J.L. : Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med, 322: 1689–1692, 1990.

Thomas M.J.G. Gillon J. Desmond M.J. : Preoperative autologous donation. Transfusion, 36: 633–639, 1996.

Kickler T.S. Spivak J.L. : Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. JAMA, 260: 65–67, 1988.

Cazzola M. Mercuriali F. Brugnara C. : Use of recombinant human erythropoietin outside the setting of uremia. Blood, 89: 4248–4267, 1997.

Mercuriali F. Gualtieri G. Sinigallia L. Inghilleri G. Biffi E. Vinci A. Colotti M.T. Barosi G. Lambertenghi Deliliers G. : Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Transfusion, 34: 501–506, 1994.

Jeekel J. : Autologous blood donation and epoetin alfa in cancer surgery. Semin Hematol, 33(suppl 2): 43–47, 1996.

Busch O.R. Hoynck van Papendrecht M.A.W. Marquet R.L. Jeekel J. : Experimental and clinical results of perioperative treatment with recombinant human erythropoietin. In: Pathophysiology and pharmacology of erythropoietin, Pagel H , Weiss C , Jelkmann W (Eds), pp 315–320, Springer Verlag, Berlin, Germany, 1992.

Heiss M.M. Mempel W. Jauch K.W. Delanoff C. Mayer G. Mempel M. Eissner H.J. Schildberg F.W. : Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet, 342: 1328–1333, 1993.